ArticleBMC cancer2016

Tyrosine kinase inhibitor SU11274 increased tumorigenicity and enriched for melanoma-initiating cells by bioenergetic modulation.

Lucia Kucerova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.